NCT00767819View on ClinicalTrials.gov

Treatment of Patients With RAD001 With Progressive Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

May 17, 2017

Study Completion Date

May 17, 2017

Conditions
Progressive Sarcoma
Interventions
DRUG

Everolimus

2.5 and 5 mg tablets taken orally and starting dose was 10 mg daily for all patients

Trial Locations (6)

15526

Novartis Investigative Site, Bad Saarow

20133

Novartis Investigative Site, Milan

40479

Novartis Investigative Site, Düsseldorf

45147

Novartis Investigative Site, Essen

68167

Novartis Investigative Site, Mannheim

81377

Novartis Investigative Site, München

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY